Article
Chromatin Remodelers Are Regulators of the Tumor Immune Microenvironment
24 Jan 2024
Abstract excerpt
Immune checkpoint inhibitors show remarkable responses in a wide range of cancers, yet patients develop adaptive resistance. This necessitates the identification of alternate therapies that synergize with immunotherapies. Epigenetic modifiers are potent mediators of tumor-intrinsic mechanisms and have been shown to regulate immune response genes, making them prime targets for therapeutic combinations with immune...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
